BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 23361894)

  • 1. Mitochondrial-dependent anticancer activity of δ-tocotrienol and its synthetic derivatives in HER-2/neu overexpressing breast adenocarcinoma cells.
    Viola V; Ciffolilli S; Legnaioli S; Piroddi M; Betti M; Mazzini F; Pierpaoli E; Provinciali M; Galli F
    Biofactors; 2013; 39(4):485-93. PubMed ID: 23361894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gamma- and delta-tocotrienols exert a more potent anticancer effect than alpha-tocopheryl succinate on breast cancer cell lines irrespective of HER-2/neu expression.
    Pierpaoli E; Viola V; Pilolli F; Piroddi M; Galli F; Provinciali M
    Life Sci; 2010 Apr; 86(17-18):668-75. PubMed ID: 20188744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin E analogs trigger apoptosis in HER2/erbB2-overexpressing breast cancer cells by signaling via the mitochondrial pathway.
    Wang XF; Witting PK; Salvatore BA; Neuzil J
    Biochem Biophys Res Commun; 2005 Jan; 326(2):282-9. PubMed ID: 15582575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel synthetic analog of Militarin, MA-1 induces mitochondrial dependent apoptosis by ROS generation in human lung cancer cells.
    Yoon DH; Lim MH; Lee YR; Sung GH; Lee TH; Jeon BH; Cho JY; Song WO; Park H; Choi S; Kim TW
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):659-71. PubMed ID: 24161344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of annatto-tocotrienols supplementation on the development of mammary tumors in HER-2/neu transgenic mice.
    Pierpaoli E; Viola V; Barucca A; Orlando F; Galli F; Provinciali M
    Carcinogenesis; 2013 Jun; 34(6):1352-60. PubMed ID: 23430951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. alpha-Tocopherol attenuates the cytotoxic effect of delta-tocotrienol in human colorectal adenocarcinoma cells.
    Shibata A; Nakagawa K; Sookwong P; Tsuduki T; Asai A; Miyazawa T
    Biochem Biophys Res Commun; 2010 Jun; 397(2):214-9. PubMed ID: 20493172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor effect of novel berberine derivatives in breast cancer cells.
    Pierpaoli E; Arcamone AG; Buzzetti F; Lombardi P; Salvatore C; Provinciali M
    Biofactors; 2013; 39(6):672-9. PubMed ID: 24000115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative hepatoprotective effects of tocotrienol analogs against drug-induced liver injury.
    Tan CY; Saw TY; Fong CW; Ho HK
    Redox Biol; 2015; 4():308-20. PubMed ID: 25637740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surfactin induces apoptosis in human breast cancer MCF-7 cells through a ROS/JNK-mediated mitochondrial/caspase pathway.
    Cao XH; Wang AH; Wang CL; Mao DZ; Lu MF; Cui YQ; Jiao RZ
    Chem Biol Interact; 2010 Feb; 183(3):357-62. PubMed ID: 19954742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deltonin induces apoptosis in MDA‑MB‑231 human breast cancer cells via reactive oxygen species‑mediated mitochondrial dysfunction and ERK/AKT signaling pathways.
    Zhang S; He Y; Tong Q; Chen Q; Wu X; Huang W
    Mol Med Rep; 2013 Mar; 7(3):1038-44. PubMed ID: 23314115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The potential of vitamin K3 as an anticancer agent against breast cancer that acts via the mitochondria-related apoptotic pathway.
    Akiyoshi T; Matzno S; Sakai M; Okamura N; Matsuyama K
    Cancer Chemother Pharmacol; 2009 Dec; 65(1):143-50. PubMed ID: 19449007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytotoxicity and apoptotic activities of alpha-, gamma- and delta-tocotrienol isomers on human cancer cells.
    Lim SW; Loh HS; Ting KN; Bradshaw TD; Zeenathul NA
    BMC Complement Altern Med; 2014 Dec; 14():469. PubMed ID: 25480449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. δ-Tocotrienol treatment is more effective against hypoxic tumor cells than normoxic cells: potential implications for cancer therapy.
    Shibata A; Nakagawa K; Tsuduki T; Miyazawa T
    J Nutr Biochem; 2015 Aug; 26(8):832-40. PubMed ID: 25979648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CR108, a novel vitamin K3 derivative induces apoptosis and breast tumor inhibition by reactive oxygen species and mitochondrial dysfunction.
    Yang CR; Liao WS; Wu YH; Murugan K; Chen C; Chao JI
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):611-22. PubMed ID: 24128853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling.
    Park SK; Sanders BG; Kline K
    Breast Cancer Res Treat; 2010 Nov; 124(2):361-75. PubMed ID: 20157774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatty acid synthase inhibition by amentoflavone suppresses HER2/neu (erbB2) oncogene in SKBR3 human breast cancer cells.
    Lee JS; Sul JY; Park JB; Lee MS; Cha EY; Song IS; Kim JR; Chang ES
    Phytother Res; 2013 May; 27(5):713-20. PubMed ID: 22767439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor anti-angiogenic effect and mechanism of action of delta-tocotrienol.
    Shibata A; Nakagawa K; Sookwong P; Tsuzuki T; Oikawa S; Miyazawa T
    Biochem Pharmacol; 2008 Aug; 76(3):330-9. PubMed ID: 18599020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimethoxycurcumin-induced cell death in human breast carcinoma MCF7 cells: evidence for pro-oxidant activity, mitochondrial dysfunction, and apoptosis.
    Kunwar A; Jayakumar S; Srivastava AK; Priyadarsini KI
    Arch Toxicol; 2012 Apr; 86(4):603-14. PubMed ID: 22119759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming trastuzumab resistance in HER2-overexpressing breast cancer cells by using a novel celecoxib-derived phosphoinositide-dependent kinase-1 inhibitor.
    Tseng PH; Wang YC; Weng SC; Weng JR; Chen CS; Brueggemeier RW; Shapiro CL; Chen CY; Dunn SE; Pollak M; Chen CS
    Mol Pharmacol; 2006 Nov; 70(5):1534-41. PubMed ID: 16887935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin induces apoptosis in breast cancer cell lines and delays the growth of mammary tumors in neu transgenic mice.
    Masuelli L; Benvenuto M; Fantini M; Marzocchella L; Sacchetti P; Di Stefano E; Tresoldi I; Izzi V; Bernardini R; Palumbo C; Mattei M; Lista F; Galvano F; Modesti A; Bei R
    J Biol Regul Homeost Agents; 2013; 27(1):105-19. PubMed ID: 23489691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.